Skip to content

S. 355 · 119th Congress (2025–2027)

FDA Modernization Act 3.0

This bill requires the Food and Drug Administration (FDA) to publish an interim final rule implementing a provision of the Consolidated Appropriations Act of 2023 that authorized the use of certain alternatives to animal testing to support investigational use of a new drug.

The rule must replace references to animal tests, data, studies, models, and research with references to nonclinical tests, data, studies, models, and research throughout the FDA’s regulations governing investigational new drug applications, and may make other changes to the regulations as appropriate.

The rule must be published within one year of the bill’s enactment, and must take immediate effect as an interim final rule.

Show official title

A bill to require the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to publish a final rule relating to nonclinical testing methods.

Passed Senate

This bill’s path

316 days after it was introduced

This is S. 355’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced10 months

  2. Passed Senate

  3. Passed House

  4. Sent to President

  5. Signed into law

Sponsor
Sen. Cory A. Booker (D-NJ)
Cosponsors
9 cosponsors

8 original · 1 later

4 R · 4 D · 1 I

  1. Sen. Richard Blumenthal (D-CT)· Original · Feb 3, 2025
  2. Sen. Angus S. King Jr. (I-ME)· Original · Feb 3, 2025
  3. Sen. John Kennedy (R-LA)· Original · Feb 3, 2025
  4. Sen. Ben Ray Luján (D-NM)· Original · Feb 3, 2025
  5. Sen. Roger Marshall (R-KS)· Original · Feb 3, 2025
  6. Sen. Rand Paul (R-KY)· Original · Feb 3, 2025
  7. Sen. Eric Schmitt (R-MO)· Original · Feb 3, 2025
  8. Sen. Sheldon Whitehouse (D-RI)· Original · Feb 3, 2025
  9. Sen. Adam B. Schiff (D-CA)· Later · Jul 22, 2025
Policy area
Health
Subjects
  • Administrative law and regulatory procedures
  • Department of Health and Human Services
  • Drug safety, medical device, and laboratory regulation
  • Medical research
  • Research administration and funding

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

1 amendment
  1. Dec 16, 2025 · S.Amdt. 4057 · adopted
  1. Introduced in Senate

    Document: Introduced in Senate

    Sources
  2. Referred to committee

    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

    Sources
  3. S.Amdt. 4057, adopted

    Major substitute

    Offered by Sen. Cory A. Booker (D-NJ)

    Amendment SA 4057 agreed to in Senate by Unanimous Consent.

    In the nature of a substitute.

    Document: Engrossed in Senate

    Sources
  4. Committee discharged

    Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent.

    Sources
  5. Latest

    Passed Senate

    Congressional Record S8794

    Passed Senate with an amendment by Unanimous Consent.

    The Senate passed the amended bill.

    Document: Engrossed in Senate

    Sources

Committees

  1. SenateHealth, Education, Labor, and PensionsReferred Feb 3, 2025

Floor record

i

Explicit consideration evidence: the measure’s bill-status citation matched a GovInfo title, headline, or first paragraph. Incidental mentions are not listed.

  1. Dec 16, 2025 · Senate · Measure laid before Senate by unanimous consentCongressional Record S8793–S8794

    Fda Modernization Act 3.0

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in Senate
Engrossed in Senate
Titles (2)
  1. FDA Modernization Act 3.0

    Display title, Short title · Engrossed in Senate, Introduced in Senate

  2. A bill to require the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to publish a final rule relating to nonclinical testing methods.

    Official title · Introduced in Senate